Document Detail

Pharmacoeconomic assessment of therapy for invasive aspergillosis.
MedLine Citation:
PMID:  23311989     Owner:  NLM     Status:  Publisher    
Invasive aspergillosis (IA) is a major cause of morbidity and mortality in immunocompromised hosts. Economic expenditures prompted by this invasive fungal infection (IFI) are significant. Although, the duration and associated costs of hospitalization comprise the largest proportion of costs in large surveillance studies, the newer oral antifungal agents may impact significantly on these costs. A review of the pharmacoeconomic (PE) studies is provided focussing on primary therapy, salvage therapy, empiric therapy and prophylaxis for IA. PE evaluations have demonstrated the cost effectiveness and dominance of voriconazole for targeted primary treatment of IA compared with other available agents. Differences in the drug choice and analytic methodology of the PE analyses of empiric antifungal strategy hamper definitive conclusions about the agents employed as empiric antifungal that may be directed at suspected IA although both caspofungin and voriconazole appear to be cost effective and dominant over liposomal amphotericin B (LAmB), whereas LAmB is more costly than conventional amphotericin B. Posaconazole is the most cost-effective agent for antifungal prophylaxis against IFI and IA.
Me-Linh Luong; Shahid Husain; Coleman Rotstein
Related Documents :
22765639 - What works: a realist evaluation case study of intermediaries in infection control prac...
24810619 - Isolation and partial characterization of bacteriophages infecting pseudomonas syringae...
24780919 - Antioxidants: potential antiviral agents for japanese encephalitis virus infection.
6020559 - Lysostaphin in experimental renal infections.
13695179 - Studies on the pathogenesis of staphylococcal infection. iv. the effect of bacterial en...
6644839 - The radiographic evaluation of infections of the spine.
23516659 - Podoconiosis and soil-transmitted helminths (sths): double burden of neglected tropical...
3669129 - The investigation of trypanosoma brucei isolates obtained from glossina pallidipes in s...
10720529 - Unique gonococcal phenotype associated with asymptomatic infection in men and with erro...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-13
Journal Detail:
Title:  Mycoses     Volume:  -     ISSN:  1439-0507     ISO Abbreviation:  Mycoses     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8805008     Medline TA:  Mycoses     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2013 Blackwell Verlag GmbH.
Division of Infectious Diseases, Department of Medicine, University of Toronto, University Health Network, Toronto, ON, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Anticancer efficacy of a novel propofol-linoleic acid-loaded escheriosomal formulation against murin...
Next Document:  Proton-Bridge Motions in Amine Conjugate Acid Ions Having Intramolecular Hydrogen Bonds to Hydroxyl ...